InvestorsHub Logo
Followers 0
Posts 3521
Boards Moderated 0
Alias Born 03/03/2018

Re: MjMilo post# 169833

Monday, 09/30/2019 11:48:48 AM

Monday, September 30, 2019 11:48:48 AM

Post# of 203913
Yet if you look at this company..at which she has been the CSO for about one year..it is updated

https://www.linkedin.com/company/neurosense-therapeutics/


Scroll down----> https://www.neurosense-tx.com/team

She doesn't even mention OWCP..

Dr. Oron Yacoby-Zeevi
Chief Scientific Officer
Chief Scientific Officer responsible for pre-clinical studies, formulation development and company’s pipeline.

Prior to working at NeuroSense, Oron was CSO at NeuroDerm, responsible for the development of their unique formulation.
In the past, she also served as Chief Science Officer at Harlan Biotech Israel Ltd., and R&D team leader at Insight Biopharmaceuticals Ltd.
She has 20 years experience in leading research and development programs, and GLP compliant pre-clinical development of numerous small molecule drugs and biologics, in various indications, including CNS diseases.
She is the author of more than 15 patents.

DVM; The Hebrew University of Jerusalem. PhD in Microbiology and Immunology; Ben-Gurion University



OWCP is not a going concern in her life any longer...it appears it never was....

Except for the pr announcing her appointment as CSO...

Where is that noted on LinkedIN..while everything else she's done or is doing now is...

Coincidence?

Nope.

Whoever is careless with the truth in small matters cannot be trusted with important matters.
– Albert Einstein